NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global ...
News Tribune23d
NanoViricides, Inc. Has Filed its Quarterly Report | Tacoma News Tribune
NV-387 acts by a mechanism that is significantly different compared to the tested existing antiviral agents for COVID, Influenza and Poxviruses. This demonstrated broad-spectrum activity of NV-387 ...
Sacramento Bee23d
NanoViricides, Inc. Has Filed its Quarterly Report
NV-387 acts by a mechanism that is significantly different compared to the tested existing antiviral agents for COVID, Influenza and Poxviruses. This demonstrated broad-spectrum activity of NV-387 ...
Sacramento Bee3d
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to ...
Pharmabiz29d
NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field
NV-387 is ready to be a significant part of the pandemic preparedness and response arsenal, because it has already demonstrated activity against different and varied viruses including coronaviruses, ...
Mongabay29d
Science aside, we need art & philosophy for global change: Epidemiologist
After medical school, he joined the CDC and worked on various outbreaks from Ebola to poxviruses. His other passion for nature and animals led him to join Conservation International, an NGO ...